Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06117618 · ClinicalTrials.gov registry record · NA
Sepsis Electronic Prompting for Timely Intervention and Care for Inpatients
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 12,284
- Enrollment target
NCT06117618: Completed NA study, sponsored by Columbia University.
NCT06117618 is a NA study that has completed, run by Columbia University. The registered enrollment target is 12,284 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (776% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06117618, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 12,284 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to study systemic inflammatory response syndrome (SIRS) electronic health record (EHR) alerts for sepsis in the inpatient setting. The main question it aims to answer is: do nurse alerts, prescribing clinician alerts, or both nurse and prescribing clinician alerts improve time to sepsis treatment for patients in the inpatient setting? Nurses and prescribing clinicians will receive SIRS alerts based on the group to which the patient is randomly assigned. Researchers will compare four groups: no alerts, nurse alerts only, prescribing clinician alerts only, or both nurse and prescribing clinician alerts.
Primary Outcome
The primary outcome is whether a patient receives a modified SSC hour-1 bundle within three hours from the time of first SIRS alert. The modified SSC hour-1 bundle includes (1) lactate lab collected, (2) two blood cultures collected, (3) new intravenous antimicrobial administration (from the Centers for Disease Control and Prevention (CDC) Adult Sepsis Event (ASE) list). Patients will be tallied.
Interventions
- OTHER Nurse SIRS alert
- OTHER Prescribing clinician SIRS alert
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12,284 participants |
| Start Date | 2023-11-14 |
| Est. Completion | 2024-07-22 |
| Phase | NA |
What the finished NCT06117618 record still lists
NCT06117618 is an interventional study that assigns participants to a tested intervention. Its 12,284 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (776% higher).
The record links to 0 conditions, and to 2 interventions - of which Nurse SIRS alert is the first listed.
NCT06117618 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06117618 about?
NCT06117618 is a clinical study titled "Sepsis Electronic Prompting for Timely Intervention and Care for Inpatients". The goal of this clinical trial is to study systemic inflammatory response syndrome (SIRS) electronic health record (EHR) alerts for sepsis in the inpatient setting. The main question it aims to answer is: do nurse alerts, prescribing clinician alerts, or both nurse and prescribing clinician alerts ...
What is the current status of trial NCT06117618?
This trial is currently completed. It is a NA study. The enrollment target is 12,284 participants. The study started on 2023-11-14. Estimated completion is 2024-07-22.
What interventions are being tested in trial NCT06117618?
The interventions under investigation include: Nurse SIRS alert (OTHER), Prescribing clinician SIRS alert (OTHER).
Who is sponsoring clinical trial NCT06117618?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06117618's enrollment target sits among peer trials
12,284 14th of 2000 higher than 1,987 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04888832 · 12,500 participants · NA
The Effect of Work Requirements in SNAP in Virginia
- NCT05452941 · 12,500 participants
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
- NCT07069556 · 12,500 participants
ColoSense Post-Approval Study
- NCT01772771 · 12,000 participants
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI